ES2164231T3 - Antigeno de helicobacter pylori. - Google Patents

Antigeno de helicobacter pylori.

Info

Publication number
ES2164231T3
ES2164231T3 ES96902390T ES96902390T ES2164231T3 ES 2164231 T3 ES2164231 T3 ES 2164231T3 ES 96902390 T ES96902390 T ES 96902390T ES 96902390 T ES96902390 T ES 96902390T ES 2164231 T3 ES2164231 T3 ES 2164231T3
Authority
ES
Spain
Prior art keywords
antigen
helicobacter pylori
well
pylori
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96902390T
Other languages
English (en)
Inventor
Christopher John Smith
Robert Llewellyn Clancy
Allan Cripps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Provalis UK Ltd
Original Assignee
Provalis UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provalis UK Ltd filed Critical Provalis UK Ltd
Application granted granted Critical
Publication of ES2164231T3 publication Critical patent/ES2164231T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN NUEVO ANTIGENO DE H. PYLORI, ASI COMO A SU USO EN EL DIAGNOSTICO DE LA INFECCION POR H. PYLORI, INCLUYENDO METODOS PARA DICHO DIAGNOSTICO Y KITS PARA SU UTILIZACION EN DICHO METODO. LA INVENCION SE REFIERE ASIMISMO A NUEVOS FRAGMENTOS ANTIGENICOS DEL ANTIGENO, ASI COMO A VACUNAS QUE COMPRENDEN BIEN EL ANTIGENO O BIEN UNO O VARIOS FRAGMENTOS ANTIGENICOS.
ES96902390T 1995-02-15 1996-02-15 Antigeno de helicobacter pylori. Expired - Lifetime ES2164231T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502899.9A GB9502899D0 (en) 1995-02-15 1995-02-15 Novel antigen

Publications (1)

Publication Number Publication Date
ES2164231T3 true ES2164231T3 (es) 2002-02-16

Family

ID=10769595

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96902390T Expired - Lifetime ES2164231T3 (es) 1995-02-15 1996-02-15 Antigeno de helicobacter pylori.

Country Status (17)

Country Link
EP (1) EP0809653B1 (es)
JP (1) JPH11503999A (es)
KR (1) KR19980701698A (es)
CN (1) CN1175955A (es)
AT (1) ATE206138T1 (es)
AU (1) AU714222B2 (es)
CA (1) CA2212952A1 (es)
DE (1) DE69615537T2 (es)
DK (1) DK0809653T3 (es)
ES (1) ES2164231T3 (es)
FI (1) FI973335L (es)
GB (1) GB9502899D0 (es)
IL (1) IL117151A (es)
NO (1) NO973753D0 (es)
NZ (1) NZ301334A (es)
PT (1) PT809653E (es)
WO (1) WO1996025430A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
CN1105185C (zh) * 1998-11-30 2003-04-09 上海晶莹生物技术有限公司 基因表达幽门螺杆菌细胞毒素相关基因a蛋白抗原制备工艺
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
SE0101030D0 (sv) * 2001-03-23 2001-03-23 Nordic Bio Ab Immunogenic cell surface proteins of helicobacter pylori

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
EP0638175B1 (en) * 1992-04-29 1998-06-17 Auspharm International Limited In vitro test for helicobacter pylori

Also Published As

Publication number Publication date
IL117151A0 (en) 1996-06-18
PT809653E (pt) 2002-03-28
FI973335A7 (fi) 1997-08-14
JPH11503999A (ja) 1999-04-06
DK0809653T3 (da) 2001-11-19
CA2212952A1 (en) 1996-08-22
ATE206138T1 (de) 2001-10-15
EP0809653B1 (en) 2001-09-26
MX9706267A (es) 1997-11-29
WO1996025430A1 (en) 1996-08-22
FI973335A0 (fi) 1997-08-14
AU714222B2 (en) 1999-12-23
KR19980701698A (ko) 1998-06-25
CN1175955A (zh) 1998-03-11
NO973753L (no) 1997-08-14
FI973335L (fi) 1997-08-14
NZ301334A (en) 1999-08-30
DE69615537T2 (de) 2002-04-18
AU4672896A (en) 1996-09-04
NO973753D0 (no) 1997-08-14
DE69615537D1 (en) 2001-10-31
EP0809653A1 (en) 1997-12-03
IL117151A (en) 2001-06-14
GB9502899D0 (en) 1995-04-05

Similar Documents

Publication Publication Date Title
NI200800193A (es) Anticuerpos humanos anti-il-23, composiciones, métodos y usos.
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
ECSP10010653A (es) Anticuerpos anti-il-17a/il-17f de reactividad cruzada y métodos de uso de los mismos
PL365951A1 (pl) Związki oraz sposoby leczenia i diagnozowania infekcji Chlamydia
DK1203817T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
CR10530A (es) Anticuerpos anti-dlla4 y metodos que los usan
BRPI0601896A (pt) composições que contêm microgéis e agentes espessantes
DK1535068T3 (da) Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekreter
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
WO2002024739A3 (en) Spas-1 cancer antigen
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
ES2187796T3 (es) Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.
ES2164231T3 (es) Antigeno de helicobacter pylori.
MXPA05000119A (es) Sistema y metodo para analisis de un tejido.
WO2003027250A3 (en) Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
DK1173766T3 (da) Isoform af tenascin-C som markör for neoplasier
WO2003006665A8 (en) Lawsonia intracellularis
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
WO2003010199A3 (en) Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
WO2005016952A3 (en) Polyvalent immunogen
BR0104357A (pt) Uso de receptores de toxina gbs ou fragmentos imunogênicos dela para prevenir uma condição patoangiogênica em um mamìfero
BR0116704A (pt) Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes
ATE375170T1 (de) Adjuvanskombinationen zur immunisierung und vakzine
BR0318114A (pt) Vacinação ou imunização utilizando um regime de iniciação-reforço
EP1319089A4 (en) IN VITRO TEST PROCEDURE FOR DETERMINING THE IMMUNOGENICITY OF A VACCINE

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 809653

Country of ref document: ES